Back

Efficacy and safety of dysopiramide in patients with obstructive hypertrophic cardiomyopathy

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 4 - Treatment aspects of hypertrophic cardiomyopathy Treatment ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Carlo Fumagalli

University of Campania Luigi Vanvitell, Naples (Italy)

9 More presentations in this session

Presentation thumbnail
Predictors of ACEI/ ARB therapy in patients with hypertrophic cardiomyopathy: results of a national registry.
Assistant Professor E. Martins (Porto, PT)
Abstract
Presentation thumbnail
Result of surgical treatment of obstructive hypertrophic cardiomyopathy with coronary heart disease
Doctor Y. Meng (Beijing, CN)
Presentation thumbnail
Comparative effectiveness of alcohol septal ablation versus septal myectomy on acute cardiovascular events in patients with hypertrophic cardiomyopathy
Associate Professor H. Takayama (New York, US)
Abstract
Presentation thumbnail
Predictors of long-term outcome after rescue surgical septal myectomy in hypertrophic obstructive cardiomyopathy patients with previous alcohol septal ablation
Doctor C. Zhu (Beijing, CN)
Abstract
Presentation thumbnail
Clinical significance of impaired cardiac conduction after alcohol septal ablation
Mr M. Jensen (Aarhus, DK)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 4 - Treatment aspects of hypertrophic cardiomyopathy

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources